Paul M Tasker, FRCS, Joan Braganza, DSc, FRCP, Harbans Sharma, MSc, PhD, DSc. Manchester Royal Infirmary.
INTRODUCTION:
Clinical studies were carried out to validate the measurement of 64Cu absorption by a computer-assisted deconvolution.
METHOD:
After an oral dose of 64Cu (250 µCi), a plasma appearance curve was derived over 10 h from sequential blood samples. On a separate occasion after an injected dose of 64Cu (125 µCi), a plasma disappearance curve was similarly constructed. To remove the caeruloplasmin component in each curve, serum samples after counting were mixed in solution with sodium diethyldithiocarbamate and passed through activated charcoal columns; this separated non-caeruloplasmin-64Cu from 64Cu-caeruloplasmin contained in the eluate. Serum activity not bound to caeruloplasmin was determined by subtraction of the weight-corrected activities of 64Cu-caeruloplasmin and the complete sample. Both curves of non-caeruloplasmin data were matched by relating the data to the same dose level by the process of normalisation. Deconvolution of this data determined cumulative 64Cu absorption.
RESULTS:
Column validation tests consisted of quantitative elution of caeruloplasmin, full adsorption of non-caeruloplasmin bound 64Cu, and protein spectrum in the eluate, which was unaltered. At the levels of serum 64Cu reached in all the studies "in vivo" there was a minimal leak of 64Cu in the eluate (< 1 %). Unless 64Cu-caeruloplasmin was present practically no activity would appear in the eluate using either plastic (containing more than 130 mg charcoal) or the glass columns (containing more than > 200 mg charcoal).
The procedure is discussed in one subject (investigator data) with three sets of data.
IV – 1 IV – 2 IV – 3 Mean ± S.D.
Oral – 1 VT (1,1) = 51.17 VT (1,2) = 52.44 VT (1,3) = 46.41 50.0 3.2
Oral – 2 VT (2,1) = 50.30 VT (2,2) = 51.71 VT (2,3) = 45.75 49.3 3.1
Oral – 3 VT (3,1) = 34.39 VT (3,2) = 35.21 VT (3,3) = 31.22 33.6 2.0
CONCLUSION: Against three I.V. tests, the percentage absorption is the same for the first two oral tests. A late meal was taken on the third test producing a lower absorption for the third test. The validation studies for the method is presented. There was a uniformity and reproducibility in the values of copper absorbed provided the protocol was rigidly adhered to and the subject remained on the habitual diet for three days before the test.
View Poster
« Return to SAGES 2014 abstract archive
